Jazz Pharmaceuticals (JAZZ) Business Metrics | Revenue Breakdown & Segment Analysis - Stocknear

Jazz Pharmaceuticals

NASDAQ: JAZZ · Real-Time Price · USD
127.00
-0.80 (-0.63%)
At close: Sep 26, 2025, 3:59 PM
127.00
0.00%
After-hours: Sep 26, 2025, 05:59 PM EDT

Defitelio Defibrotide Revenue

History

Quarter Value Change Growth
Jun 30, 2025 48.11M 7.44M +18.31%
Mar 31, 2025 40.66M -16.99M -29.47%
Dec 31, 2024 57.65M -8.17M -12.41%
Sep 30, 2024 65.82M 20.4M +44.91%
Jun 30, 2024 45.42M -2.25M -4.73%
Mar 31, 2024 47.68M -54K -0.11%
Sep 30, 2023 47.73M 1.62M +3.52%
Jun 30, 2023 46.11M 7.03M +17.99%
Mar 31, 2023 39.08M -1.57M -3.87%
Dec 31, 2022 40.65M -8.8M -17.79%
Sep 30, 2022 49.45M -5.24M -9.59%
Jun 30, 2022 54.7M 5.21M +10.52%
Mar 31, 2022 49.49M 6.98M +16.41%
Dec 31, 2021 42.51M -15.19M -26.33%
Sep 30, 2021 57.7M 9.61M +19.98%
Jun 30, 2021 48.1M -1.52M -3.07%
Mar 31, 2021 49.62M -5.84M -10.52%
Dec 31, 2020 55.45M 5.21M +10.38%
Sep 30, 2020 50.24M 7.53M +17.62%
Jun 30, 2020 42.71M -4.72M -9.95%
Mar 31, 2020 47.43M -347K -0.73%
Dec 31, 2019 47.78M 10.18M +27.06%
Sep 30, 2019 37.6M -8.45M -18.35%
Jun 30, 2019 46.05M 4.55M +10.98%
Mar 31, 2019 41.5M 3.79M +10.04%
Dec 31, 2018 37.71M 1.53M +4.24%
Sep 30, 2018 36.18M 32.17M +803.52%
Jun 30, 2018 4M -2.02M -33.58%
Mar 31, 2018 6.03M 2.59M +75.49%
Dec 31, 2017 3.44M -2.63M -43.37%
Sep 30, 2017 6.07M -645K -9.61%
Jun 30, 2017 6.71M 364K +5.73%
Mar 31, 2017 6.35M -1.75M -21.65%
Dec 31, 2016 8.1M -243.65M -96.78%
Dec 31, 2015 251.75M 8.85M +3.64%
Sep 30, 2015 242.9M -4.95M -2.00%
Jun 30, 2015 247.85M 35.16M +16.53%
Mar 31, 2015 212.69M -9.81M -4.41%
Dec 31, 2014 222.5M 18.17M +8.89%
Sep 30, 2014 204.34M 12.97M +6.78%
Jun 30, 2014 191.37M 30.99M +19.32%
Mar 31, 2014 160.38M -3.8M -2.32%
Dec 31, 2013 164.18M 10.52M +6.84%
Sep 30, 2013 153.66M 19.92M +14.90%
Jun 30, 2013 133.74M 16.22M +13.80%
Mar 31, 2013 117.53M 4.01M +3.53%
Dec 31, 2012 113.51M 10.9M +10.62%
Sep 30, 2012 102.61M 13.52M +15.17%
Jun 30, 2012 89.1M 15.66M +21.32%
Mar 31, 2012 73.44M n/a n/a